Clinical Trials Browser

Triple Negative Breast Neoplasms

Genital Neoplasms, Male

Stomach Neoplasms

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Adenocarcinoma, Pancreatic Neoplasms

Leiomyosarcoma, Neoplasm Metastasis, Sarcoma

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Pancreatic Neoplasms

Resectable Pancreatic Cancer

Mesothelioma, Malignant

Metastatic Adenocarcinoma of the Pancreas

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Advanced Pancreatic Carcinoma

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Neoplasms, Pancreatic Neoplasms

Biliary Tract Neoplasms

Lymphoma, Large B-Cell, Diffuse

Nasopharyngeal Carcinoma

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Osteosarcoma

Recurrence, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Fibrosis, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Urinary Bladder Neoplasms

Gastrointestinal Neoplasms

Urinary Bladder Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

Clinical Trials

TRIFOUR

Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

NABPLAGEMD

TARSARC

EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

SLAT

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

INFINITE

NAPOLI 3

KEYNOTE-966

HCW9218 for Advanced Pancreatic Cancer

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

INCA

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

KEYNOTE-966

Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy

BREGO

Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy

KEYLYNK-009